99
Views
1
CrossRef citations to date
0
Altmetric
Review

Review of adult attention-deficit/hyperactivity disorder in South Africa

&
Pages 343-353 | Received 14 Jun 2017, Accepted 20 Jul 2017, Published online: 27 Jul 2017

References

  • Du Plessis AME. Attention-deficit/hyperactivity disorder. S Afr Fam Pract. 2015;57(3):24–28.
  • Schoeman R. Costly adult ADHD shunned by medical aids. SAMJ. 2016;106(5):431.
  • Verbeeck WJC. Attention deficit hyperactivity disorder in adults: diagnostic imperatives. SA Psych Rev. 2003;6:7–10.
  • Vogel W. An update on attention deficit hyperactivity disorder (ADHD). SAMJ. 2014;104(1):72–74.
  • Walker S, Venter A, van der Walt A, et al. Prevalence of attention-deficit/hyperactivity disorder (ADHD) symptomatology and psychiatric co-morbidity among adolescents diagnosed with ADHD in childhood. SAJP. 2011;17:24–28.
  • Corbisiero S, Stieglitz RD, Retz W, et al. Is emotional dysregulation part of the psychopathology of ADHD in adults? ADHD. 2013;5:83–92.
  • Surman CBH, Biederman J, Spencer T, et al. Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. Am J Psychiatry. 2011;168(6):617–623.
  • De Schipper E, Mahdi S, Coghill D, et al. Towards an ICF core set for ADHD: a worldwide expert survey on ability and disability. Eur Child Adolesc Psychiatry. 2015;24:1509–1521.
  • Froehlich TE, Lanphear BP, Epstein JN, et al. Prevalence recognition, and treatment of attention- deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adoles Med. 2007;161:857–864.
  • Brown TE. DSM-IV: ADHD and executive function impairments. Proc. 2002;2:910–914.
  • Goodman DW. Sustained treatment effect in attention deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies. Ther Clin Risk Manag. 2013;9:121–130.
  • Simon V, Czobor P, Balint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194:204–211.
  • Davidson MA. ADHD in adults, a review of the literature. J Atten Disord. 2008;11:628–641.
  • Mahomedy Z, Van Der Westhuizen D, Van Der Linde MJ, et al. Persistence of attention deficit/hyperactivity disorder into adulthood: a study conducted on parents of children diagnosed with attention deficit/hyperactivity disorder. S Afr Psychiatry Rev. 2007;10:93–98.
  • Burke A, Austin TL. The problem of Identifying and diagnosing adult attention deficit hyperactivity disorder (AADHD): results and implications of a South African study. J Psychol Afr. 2010;20(2):265–274.
  • Panzer A, Viljoen M. Supportive neurodevelopmental evidence for ADHD as a developmental disorder. Med Hypotheses. 2005;64:755–758.
  • Johansen EB, Killeen PR, Russell AA, et al. Origins of altered reinforcement effects in ADHD. Behav Brain Funct. 2009;5(7):869–871.
  • Kleintjes S, Flisher AJ, Fick M, et al. The prevalence of mental disorders among children, adolescents and adults in the Western Cape, South Africa. S Afr Psychiatry Rev. 2006;9:157–160.
  • Leary PM. GP review hyperactivity. SAMJ. 1988;6:869–871.
  • Venter A. Attention deficit/hyperactivity disorder (ADHD). CME. 2004;22(8):444–448.
  • Schellack N, Meyer JC. The management of attention-deficit/hyperactivity disorder in children: updated 2016. SAPJ. 2016;83(4):21–29.
  • Burke A, Austin TL, Waldeck C. Adult ADHD in a student population: preliminary findings. J Psychol Afr. 2011;21(1):27–32.
  • Burke A, Vorster A. Prevalence rates of comorbid disorders in attention deficit hyperactivity disorder adults. S Afr J Psychol. 2016;46(2):244–253.
  • Geeimooi NL. Investigating the relationship between adult attention deficit and hyperactivity disorder (AADHD) and personality correlates related to sensation seeking. New Voices Psychol. 2015;11(1):80–111.
  • King K, Alexander D, Seabi J. Siblings’ perceptions of their ADHD-diagnosed sibling’s impact on the family system. Int J Environ Res Public Health. 2016;13(9):910.
  • Louw C, Oswald MM, Perold MD. General practitioners’ familiarity, attitudes and practises with regard to Attention Deficit Hyperactivity Disorder (ADHD) in children and adults. S Afr Fam Pract. 2009;51(2):152–157.
  • Prinsloo J, Hesselink A. Mental Health disorders and crime: an International comparison. South Afr J Criminology. 2015;28(1):1–11.
  • Sayce S, Burke A. Nicotine exposure effects on ADHD in young adults with Attention Deficit Hyperactive Disorder (ADHD). J Psychol Afr. 2014;24(5):437–444.
  • Schoeman R, De Klerk M, Kidd M. Attention deficit hyperactivity disorder in adults: a South African perspective. ADHD in focus. 2015;3(2):9–12.
  • Truter I. Methylphenidate: prescribing patterns in a South African primary care patient population. J Clin Pharm Ther. 2005;30:59–63.
  • Truter I, Kotze TJ, van W. Prescribing patterns of methylphenidate in a South African patient population who are members of a private medical aid. Health SA Gesondheid. 2005;10(4):75–84.
  • Truter I. Prescribing patterns of methylphenidate and atomoxetine for patients with Attention-Deficit/Hyperactivity Disorder. Trop J Pharm Res. 2014;13(7):1157–1162.
  • Greeff D. Are you paying enough attention to ADHD? PNT. 2005;9(5):38.
  • Korb FA. ADD/ADHD in adulthood. MHM. 2014;1(2);Sep;23–25.
  • Schuler CE. ADHD and psychiatric co-morbidities. MHM. 2015;2(2):45–48.
  • Van der Merwe E. Modafinil, Newer anti-epileptic drugs, lipid lowering, and hormone therapy-associated asthma. CME. 2004;22(8):475–476.
  • Van der Westhuizen A. Evidence-based pharmacy practice (EBPP): attention deficit hyperactivity disorder (ADHD). SAPJ. 2010;77(8);Sep:10–20.
  • Van Schalkwyk GI, Schronen J. Attention-deficit hyperactivity disorder in adults: a guide for the general practitioner. SAfrFam Pract. 2011;53(2):131–134.
  • Venter A. The medical management of attention-deficit/hyperactivity disorder: spoilt for choice? S Afr Psychiatry Rev. 2006;9:143–151.
  • Venter A. Adult ADHD. Specialist Forum. 2015;15(10):42–45.
  • Bangs ME, Wietecha LA, Wang MS, et al. Meta-Analysis of suicide-related behaviour or ideation in child, adolescent and adult patients treated with atomoxetine. J Child Adolesc Psychopharmacol. 2014;24(8):426–434.
  • Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The WHO World Mental Health (WMH) Surveys. Psychiatrie. 2009;6(1):5–9.
  • Russell VA, Oades RD, Tannock R, et al. Response variability in attention-deficit/hyperactivity disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct. 2006;2:30.
  • Seedat S, Scott KM, Angermeyer MC, et al. Cross-national associations between gender and mental disorders in the WHO World Mental Health Surveys, Arch. Gen Psychiatry. 2009;66(7):785–795.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.